XML 69 R56.htm IDEA: XBRL DOCUMENT
v3.22.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) - shares | 12 Months Ended
--- | ---
Dec. 31, 2021 | Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share |  | 3,247,715 | 2,408,600
Series A Convertible Preferred Stock [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share | [1] |  | 8,000
Series B Convertible Preferred Stock [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share |  |  | 764,400
Series B 1 Convertible Preferred Stock [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share |  |  | 48,000
Series C Convertible Preferred Stock [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share |  |  | 108,600
Series C 1 Convertible Preferred Stock [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share |  |  | 865,500
Common Stock [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share | [2] | 1,945,270 |
Underwriter [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share |  | 144,445 |
Convertible Preferred Stock [Member] |  |  |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |  |  |
Antidiluted earnings per share | [3] | 1,158,000 | 614,100
[1] | The Series A the conversion formula is aggregate Stated Value divided by IPO price (State Value for each Series A preferred shares is $1,000). These are 8,000 shares of Series A Preferred Stock issued and outstanding (10,000 shares are designated Series A). The conversion formula would be $8 million (the aggregate stated value) divided by IPO price.
[2] | The Board of Directors have approved a 10-years option at an exercise price of $6.49 per share that will be exercisable at any time.
[3] | The expiry date of warrants granted with Series C-1 was extended to June 30, 2022.

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=SOPA_SeriesAConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=SOPA_SeriesBConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=SOPA_SeriesB1ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=SOPA_SeriesCConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=SOPA_SeriesC1ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=SOPA_UnderwriterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |